Conference item
Maternal circulating levels of syncytiotrophoblast vesicles expressing Dipeptidyl Peptidase IV (DPPIV) are increased in Gestational Diabetes Mellitus
- Abstract:
- Gestational Diabetes Mellitus (GDM) is the most common metabolic disorder of pregnancy. Plasma of women with GDM display lower levels of glucagon-like peptide-1 (GLP-1), which increases insulin secretion and thus regulates glucose homeostasis. GLP-1 concentration normalizes after delivery; suggesting placental involvement in regulating maternal glucose-dependent insulin secretion. The syncytiotrophoblast of the human placenta produces and secretes extracellular vesicles (STBEVs) into the maternal circulation, by which the placenta may affect maternal metabolism. We analysed the presence of dipeptidyl peptidase IV (DPPIV), a potent inhibitor of GLP-1, on STBEVs in GDM and normal pregnancy
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Publisher copy:
- 10.1016/j.placenta.2018.06.005
Authors
- Publisher:
- Elsevier
- Host title:
- Placenta
- Journal:
- 2018 International Federation of Placenta Associations Meeting (IFPA 2018) More from this journal
- Volume:
- 69
- Pages:
- E7
- Publication date:
- 2018-09-10
- DOI:
- EISSN:
-
1532-3102
- ISSN:
-
0143-4004
- Pubs id:
-
pubs:921715
- UUID:
-
uuid:84b99b07-03ae-41f8-a3fc-6545b0b487cc
- Local pid:
-
pubs:921715
- Source identifiers:
-
921715
- Deposit date:
-
2018-10-02
- ARK identifier:
Terms of use
- Copyright holder:
- Elsevier Ltd
- Copyright date:
- 2018
- Notes:
- Copyright © 2018 Elsevier Ltd. All rights reserved. This abstract was presented at the 2018 International Federation of Placenta Associations Meeting (IFPA 2018)
If you are the owner of this record, you can report an update to it here: Report update to this record